These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
226 related articles for article (PubMed ID: 10403350)
1. Population-based screening for hemochromatosis using phenotypic and DNA testing among employees of health maintenance organizations in Springfield, Missouri. McDonnell SM; Hover A; Gloe D; Ou CY; Cogswell ME; Grummer-Strawn L Am J Med; 1999 Jul; 107(1):30-7. PubMed ID: 10403350 [TBL] [Abstract][Full Text] [Related]
2. Hemochromatosis and iron-overload screening in a racially diverse population. Adams PC; Reboussin DM; Barton JC; McLaren CE; Eckfeldt JH; McLaren GD; Dawkins FW; Acton RT; Harris EL; Gordeuk VR; Leiendecker-Foster C; Speechley M; Snively BM; Holup JL; Thomson E; Sholinsky P; N Engl J Med; 2005 Apr; 352(17):1769-78. PubMed ID: 15858186 [TBL] [Abstract][Full Text] [Related]
3. HFE mutations in Caucasian participants of the Hemochromatosis and Iron Overload Screening study with serum ferritin level <1000 µg/L. Adams PC; McLaren CE; Speechley M; McLaren GD; Barton JC; Eckfeldt JH Can J Gastroenterol; 2013 Jul; 27(7):390-2. PubMed ID: 23862168 [TBL] [Abstract][Full Text] [Related]
4. HFE genotype in patients with hemochromatosis and other liver diseases. Bacon BR; Olynyk JK; Brunt EM; Britton RS; Wolff RK Ann Intern Med; 1999 Jun; 130(12):953-62. PubMed ID: 10383365 [TBL] [Abstract][Full Text] [Related]
5. Relationships of serum ferritin, transferrin saturation, and HFE mutations and self-reported diabetes in the Hemochromatosis and Iron Overload Screening (HEIRS) study. Acton RT; Barton JC; Passmore LV; Adams PC; Speechley MR; Dawkins FW; Sholinsky P; Reboussin DM; McLaren GD; Harris EL; Bent TC; Vogt TM; Castro O Diabetes Care; 2006 Sep; 29(9):2084-9. PubMed ID: 16936157 [TBL] [Abstract][Full Text] [Related]
6. Epidemiology and diagnostic testing for hemochromatosis and iron overload. Adams PC Int J Lab Hematol; 2015 May; 37 Suppl 1():25-30. PubMed ID: 25976957 [TBL] [Abstract][Full Text] [Related]
7. Genetic screening for HFE hemochromatosis in 6,020 Danish men: penetrance of C282Y, H63D, and S65C variants. Pedersen P; Milman N Ann Hematol; 2009 Aug; 88(8):775-84. PubMed ID: 19159930 [TBL] [Abstract][Full Text] [Related]
8. Potential nonresponse bias in a clinical examination after initial screening using iron phenotyping and HFE genotyping in the hemochromatosis and iron overload screening study. Speechley M; Barton JC; Passmore L; Harrison H; Reboussin DM; Harris EL; Rivers CA; Fadojutimi-Akinsiku M; Wenzel L; Diaz S Genet Test Mol Biomarkers; 2009 Dec; 13(6):721-8. PubMed ID: 19860558 [TBL] [Abstract][Full Text] [Related]
9. Correlation between iron status and genetic hemochromatosis (codon C282Y) in a large German population. Wrede CE; Hutzler S; Bollheimer LC; Buettner R; Hellerbrand C; Schöelmerich J; Palitzsch KD Isr Med Assoc J; 2004 Jan; 6(1):30-3. PubMed ID: 14740507 [TBL] [Abstract][Full Text] [Related]
11. [Molecular genetic diagnostics and screening of hereditary hemochromatosis]. Zlocha J; Kovács L; Pozgayová S; Kupcová V; Durínová S Vnitr Lek; 2006 Jun; 52(6):602-8. PubMed ID: 16871764 [TBL] [Abstract][Full Text] [Related]
12. HFE C282Y homozygosity is associated with lower total and low-density lipoprotein cholesterol: The hemochromatosis and iron overload screening study. Adams PC; Pankow JS; Barton JC; Acton RT; Leiendecker-Foster C; McLaren GD; Speechley M; Eckfeldt JH Circ Cardiovasc Genet; 2009 Feb; 2(1):34-7. PubMed ID: 20031565 [TBL] [Abstract][Full Text] [Related]
13. Using iron studies to predict HFE mutations in New Zealand: implications for laboratory testing. O'Toole R; Romeril K; Bromhead C Intern Med J; 2017 Apr; 47(4):447-454. PubMed ID: 28019068 [TBL] [Abstract][Full Text] [Related]
14. Screening selected blood donors with biochemical iron overload for hemochromatosis: a regional experience. De Gobbi M; D'Antico S; Castagno F; Testa D; Merlini R; Bondi A; Camaschella C Haematologica; 2004 Oct; 89(10):1161-7. PubMed ID: 15477198 [TBL] [Abstract][Full Text] [Related]
15. Predicting C282Y homozygote genotype for hemochromatosis using serum ferritin and transferrin saturation values from 44,809 participants of the HEIRS study. Lim A; Speechley M; Adams PC Can J Gastroenterol Hepatol; 2014 Oct; 28(9):502-4. PubMed ID: 25314357 [TBL] [Abstract][Full Text] [Related]
16. Hereditary hemochromatosis in a Brazilian university hospital in São Paulo State (1990-2000). Martinelli AL; Filho R; Cruz S; Franco R; Tavella M; Secaf M; Ramalho L; Zucoloto S; Rodrigues S; Zago M Genet Mol Res; 2005 Mar; 4(1):31-8. PubMed ID: 15841433 [TBL] [Abstract][Full Text] [Related]
17. Screening for iron overload in the Turkish population. Barut G; Balci H; Bozdayi M; Hatemi I; Ozcelik D; Senturk H Dig Dis; 2003; 21(3):279-85. PubMed ID: 14571105 [TBL] [Abstract][Full Text] [Related]
18. Hepatic iron overload: direct HFE (HLA-H) mutation analysis vs quantitative iron assays for the diagnosis of hereditary hemochromatosis. Press RD; Flora K; Gross C; Rabkin JM; Corless CL Am J Clin Pathol; 1998 May; 109(5):577-84. PubMed ID: 9576576 [TBL] [Abstract][Full Text] [Related]
19. The effect of HFE genotypes on measurements of iron overload in patients attending a health appraisal clinic. Beutler E; Felitti V; Gelbart T; Ho N Ann Intern Med; 2000 Sep; 133(5):329-37. PubMed ID: 10979877 [TBL] [Abstract][Full Text] [Related]